Pathophysiology and Management of Acute Coronary Syndromes

Published Online: Monday, March 25, 2013
Follow Pharmacy_Times:
In this podcast from the BMJ Group, Mark de Belder, MD, a consultant cardiologist, speaks to James McLenachan, MRCP, a fellow consultant cardiologist, and Keith Channon, MD, professor of cardiovascular medicine at the University of Oxford, about the pathophysiology and management of acute coronary syndromes. To listen to the podcast online, click here. To download it, click here.
Related Articles
Digoxin is associated with a 71% increased risk of death and a 63% higher risk of hospitalization among adults diagnosed with atrial fibrillation who have no evidence of heart failure.
A Merck study found patients who received a cholesterol-lowering combination of ezetimibe/simvastatin experienced fewer major cardiovascular events than those taking simvastatin alone.
More than 40% of calls placed to US poison control centers concerning energy drinks involve children under age 6, some of whom suffer serious cardiac and neurological symptoms.
Is moderation the key to all things, including exercise?
Latest Issues
$auto_registration$